“Following Governor Hochul’s 2026 State of the State, NewYorkBIO applauds the administration’s ongoing commitment to advancing medical innovation across the state. Governor Hochul’s continued investment in life sciences through projects like the Bolstering Biotech Initiative that supports the life science sector from discovery to commercialization, alongside continued protections for immunization access, solidifies New York’s national leadership in driving medical breakthroughs.
In the coming year, NewYorkBIO will continue to work closely with the Hochul administration as we continue to grow our life science industry statewide. Together, we will revolutionize New York’s biotech industry, and empower New York companies, scientists, and entrepreneurs to enhance patient lives worldwide. We look forward to reviewing the Executive Budget as it relates to these transformative initiatives.”